- Home
- OCFT vs SGMT Comparison
OCFT vs SGMT Comparison
Compare OCFT & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- SGMT
- Stock Information
- Founded
- OCFT 2015
- SGMT 2006
- Country
- OCFT China
- SGMT United States
- Employees
- OCFT N/A
- SGMT N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- SGMT
- Sector
- OCFT Technology
- SGMT
- Exchange
- OCFT Nasdaq
- SGMT Nasdaq
- Market Cap
- OCFT 102.5M
- SGMT 93.7M
- IPO Year
- OCFT 2019
- SGMT 2023
- Fundamental
- Price
- OCFT $2.32
- SGMT $4.73
- Analyst Decision
- OCFT Strong Buy
- SGMT Strong Buy
- Analyst Count
- OCFT 1
- SGMT 5
- Target Price
- OCFT $7.00
- SGMT $21.60
- AVG Volume (30 Days)
- OCFT 45.5K
- SGMT 792.4K
- Earning Date
- OCFT 11-14-2024
- SGMT 11-13-2024
- Dividend Yield
- OCFT N/A
- SGMT N/A
- EPS Growth
- OCFT N/A
- SGMT N/A
- EPS
- OCFT 0.00
- SGMT N/A
- Revenue
- OCFT $402,566,398.00
- SGMT N/A
- Revenue This Year
- OCFT N/A
- SGMT N/A
- Revenue Next Year
- OCFT N/A
- SGMT N/A
- P/E Ratio
- OCFT $26.21
- SGMT N/A
- Revenue Growth
- OCFT N/A
- SGMT N/A
- 52 Week Low
- OCFT $0.87
- SGMT $2.31
- 52 Week High
- OCFT $4.98
- SGMT $20.71
- Technical
- Relative Strength Index (RSI)
- OCFT 46.12
- SGMT 41.81
- Support Level
- OCFT $2.37
- SGMT $5.61
- Resistance Level
- OCFT $2.75
- SGMT $6.40
- Average True Range (ATR)
- OCFT 0.26
- SGMT 0.53
- MACD
- OCFT -0.05
- SGMT -0.16
- Stochastic Oscillator
- OCFT 20.00
- SGMT 8.24
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).